Brief: Corvus Pharmaceuticals Reports Qtrly Loss Per Share $0.18
08/08/2022 23:21
Aug 8 (Reuters) - Corvus Pharmaceuticals Inc CRVS.O :
* CORVUS PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND
REPORTS
SECOND QUARTER 2022 FINANCIAL RESULTS
* CORVUS PHARMACEUTICALS INC - EXTENDS CASH RUNWAY INTO
EARLY 2024
* CORVUS PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.18
Source text for Eikon: ID:nGNXLr1ML
Further company coverage: CRVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Corvus Pharmaceuticals
See all newsBrief: Corvus Pharmaceuticals Announces Initiation Of Phase 1B Clinical Trial Of Soquelitinib For Patients With Hidradenitis Suppurativa
Corvus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental